Bladder cancer study seeks best chemo combo for surgery patients
NCT ID NCT01812369
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 21 times
Summary
This study compared two chemotherapy combinations (GC and HD-MVAC) given before or after bladder removal surgery in 500 patients with advanced bladder cancer. The goal was to see which regimen better delays cancer progression. Both treatments aim to control the disease, not cure it, and patients may need ongoing monitoring or additional therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UHRouen
Rouen, 76031, France
Conditions
Explore the condition pages connected to this study.